| pubmed-article:6446899 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C0004827 | lld:lifeskim |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C0017973 | lld:lifeskim |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C0204727 | lld:lifeskim |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:6446899 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:6446899 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6446899 | pubmed:dateCreated | 1980-9-23 | lld:pubmed |
| pubmed-article:6446899 | pubmed:abstractText | Proteoglycans of 300 000 mol.wt. were isolated from dispersed rat basophil tumour cells after labelling of the sulphated mucopolysaccharides with 35S in vitro:90% of the 35S-labelled mucopolysaccharides were extracted at high salt concentration. Alkali degradation of the 35S-labelled proteoglycans yielded glycosaminoglycan chains of 40 000 mol.wt. The composition of the salt-extracted 35S-labelled mucopolysaccharides, as defined by parallel or sequential degradation with chondroitinase AC, chondroitinase ABC and heparinase and resolution of the disaccharide-digestion products obtained with chondroitinase AC, was 48--61% chondroitin 4-sulphate, 20--30% dermatan sulphate, 10--15% heparin and 7--9% chondroitin 6-sulphate. Most of the salt-extracted 35S-labelled mucopolysaccharides were highly charged, with heparin and chondroitin 6-sulphate being relatively uniform in this regard, whereas chondroitin 4-sulphate and dematan sulphate exhibited a range of charge characteristics. The diversity of sulphated mucopolysaccharides present in the rat leukaemic basophil is in contrast with the predominance of heparin in the rat mast cell. | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6446899 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6446899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6446899 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6446899 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:6446899 | pubmed:issn | 0264-6021 | lld:pubmed |
| pubmed-article:6446899 | pubmed:author | pubmed-author:AustenK FKF | lld:pubmed |
| pubmed-article:6446899 | pubmed:author | pubmed-author:WassermanS... | lld:pubmed |
| pubmed-article:6446899 | pubmed:author | pubmed-author:MetcalfeD DDD | lld:pubmed |
| pubmed-article:6446899 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6446899 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:6446899 | pubmed:volume | 185 | lld:pubmed |
| pubmed-article:6446899 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6446899 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6446899 | pubmed:pagination | 367-72 | lld:pubmed |
| pubmed-article:6446899 | pubmed:dateRevised | 2010-9-10 | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:meshHeading | pubmed-meshheading:6446899-... | lld:pubmed |
| pubmed-article:6446899 | pubmed:year | 1980 | lld:pubmed |
| pubmed-article:6446899 | pubmed:articleTitle | Isolation and characterization of sulphated mucopolysaccharides from rat leukaemic (RBL-1) basophils. | lld:pubmed |
| pubmed-article:6446899 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6446899 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6446899 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6446899 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6446899 | lld:pubmed |
